Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
3,4-Dihydro-3-methyl-d3-4-oxo-imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 95 %
Hazard Compound
No -Refer MSDS for accurate information
Temozolomide-d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Temozolomide-d3 usage and description
Temozolomide D3 is a deuterated form of the chemotherapy drug Temozolomide. It is used in the treatment of certain types of brain tumors such as glioblastoma multiforme and anaplastic astrocytoma. Temozolomide D3 works by inhibiting the growth of cancer cells.
Temozolomide D3 is a prodrug which means it is inactive until it is metabolized by the body. Once inside the body, it is converted into its active form, which is responsible for its anti-cancer effects. It works by damaging the DNA of cancer cells, which in turn leads to their death.
The chemical formula of Temozolomide D3 is C9H6D3N5O2. It has a molecular weight of 216.22 g/mol. It is a white to light yellow crystalline powder that is soluble in water. The deuterated form of Temozolomide is used in clinical studies to determine the pharmacokinetic properties of the drug.
Temozolomide D3 is administered orally in the form of capsules. The recommended dose of the drug is determined by the patient's body weight and the type of cancer being treated. The drug is generally well tolerated, but like all chemotherapy drugs, it may cause side effects such as fatigue, nausea, vomiting, and low blood cell counts.
In conclusion, Temozolomide D3 is a deuterated form of the chemotherapy drug Temozolomide which is used in the treatment of certain types of brain tumors. It works by inhibiting the growth of cancer cells and damaging their DNA. The drug is administered orally in the form of capsules and may cause side effects such as fatigue, nausea, vomiting, and low blood cell counts.
